Vnitr Lek 2019, 65(4):295-299 | DOI: 10.36290/vnl.2019.051

Current view of treatment of hypoglycemia

Jan Brož1,*, Jana Urbanová2, Marisa Nunes1, Martina Tuháčková1, Ludmila Brunerová2, Denisa Janíčková Žďárská1
1 Interní klinika 2. LF UK a FN Motol, Praha
2 Centrum pro výzkum diabetu, metabolismu a výživy, II. interní klinika 3. LF UK a FN Královské Vinohrady, Praha

Hypoglycemia is a side effect of the therapy primarily with insulin, sulphonylurea derivates and glinides. Its therapy is based on the immediate ingestion of sacharides, preferably glucose. Amount of 15-20 g is recommended as its optimal dose, although several recent studies are suggesting amount related to the patient's weight. The therapy of severe hypoglycemia in the non-professional settings is based on glucagon injection, in the professional ones intravenous administration of glucose is preferable option.

Keywords: glucagon; glucose; hypoglycemia; therapy; type 1 diabetes; type 2 diabetes

Received: September 4, 2018; Accepted: January 31, 2019; Published: April 1, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Brož J, Urbanová J, Nunes M, Tuháčková M, Brunerová L, Janíčková Žďárská D. Current view of treatment of hypoglycemia. Vnitr Lek. 2019;65(4):295-299. doi: 10.36290/vnl.2019.051.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. McCoy RG, Van Houten HK et al. Increased mortality of patients with diabetes reporting severe hypoglycemia. Diabetes Care 2012; 35(9): 1897-1901. Dostupné z DOI: <http://dx.doi.org/10.2337/dc11-2054>. Go to original source... Go to PubMed...
    2. Hemmingsen B, Lund SS, Gluud C et al. Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials. BMJ 2011; 343: d6898. Dostupné z DOI: <http://dx.doi.org/10.1136/bmj.d6898>. Go to original source... Go to PubMed...
    3. Bolek T, Samoš M, Mokáň M et al. Akútne príčiny náhlych úmrtí u pacientov so závažnou hypoglykémiou. Vnitř Lék 2016; 62(6): 462-466. Go to PubMed...
    4. [International Hypoglycemia Study Group]. Minimizing Hypoglycemia in Diabetes. Diabetes Care 2015; 38(8): 1583-1591. Dostupné z DOI: <http://dx.doi.org/10.2337/dc15-0279>. Go to original source... Go to PubMed...
    5. American Diabetes Association. Glycemic targets. Sec. 6. In Standards of Medical Care in Diabetes - 2018. Diabetes Care 2018; 41(Suppl 1): S55-S64. Dostupné z DOI: <http://dx.doi.org/https://doi.org/10.2337/dc18-S00>. Go to original source...
    6. Diabetes Canada Clinical Practice Guidelines Expert Committee. Diabetes Canada 2018 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. Can J Diabetes 2018; 42(Suppl 1): S1-S325. Dostupné z DOI: <https://doi.org/10.1016/j.jcjd.2017.10.005>. Go to original source... Go to PubMed...
    7. [Joint British Diabetes Societies - Inpatient Care Group (JBDS-IP)]. The Hospital Management of Hypoglycaemia in Adults with Diabetes Mellitus. 3rd ed. Revised April 2018. Dostupné z WWW: <https://abcd.care/joint-british-diabetes-societies-jbds-inpatient-care-group> nebo <www.diabetes.org.uk/joint-british-diabetes-society>.
    8. Brodows RG, Williams C, Amatruda JM. Treatment of insulin reactions in diabetics. JAMA 1984; 252(24): 3378-3381. Go to original source...
    9. Slama G, Traynard PY, Desplanque N et al. The search for an optimized treatment of hypoglycemia. Carbohydrates in tablets, solutin, or gel for the correction of insulin reactions. Arch Intern Med 1990; 150(3): 589-593. Go to original source...
    10. Husband AC, Crawford S, McCoy LA et al. The effectiveness of glucose, sucrose, and fructose in treating hypoglycaemia in children with type 1 diabetes. Pediatr Diabetes 2009; 11(3): 154-158. Dostupné z DOI: <http://dx.doi.org/10.1111/j.1399-5448.2009.00558.x>. Go to original source... Go to PubMed...
    11. Brodows RG, Williams C, Amatruda JM. Treatment of insulin reactions in diabetics. JAMA 1984; 252(24): 3378-3381. Go to original source...
    12. Wiethop BV, Cryer PE. Alanine and terbutaline in treatment of hypoglycemia in IDDM. Diabetes Care 1993; 16(8): 1131-1136. Go to original source... Go to PubMed...
    13. Bryden KS, Neil A, Mayou RA et al. Eating habits, bodyweight, and insulin misuse. A longitudinal study of teenagers and young adults with type 1 diabetes. Diabetes Care 1999; 22(12): 1956-1960. Go to original source... Go to PubMed...
    14. Vindedzis S, Marsh B, Sherriff J et al. Dietary treatment of hypoglycaemia: should the Australian recommendation be increased? Intern Med J2012; 42(7): 830-833. Dostupné z DOI: <http://dx.doi.org/10.1111/j.1445-5994.2012.02831.x>. Go to original source... Go to PubMed...
    15. McTravish L, Krebs JD, Weatherall M et al. Weight-based hypoglycaemia treatment protocol for adults with Type 1 diabetes: a randomized crossover clinical trial. Diabet Med 2015; 32(9): 1143-1148. Dostupné z DOI: <http://dx.doi.org/10.1111/dme.12730>. Go to original source... Go to PubMed...
    16. McTavish L, Corley B, Weatherall M et al. Weight-based carbohydrate treatment of hypoglycaemia in people with Type 1 diabetes using insulin pump therapy: a randomized crossover clinical trial. Diabet Med 2018; 35(3): 339-346. Dostupné z DOI: <http://dx.doi.org/10.1111/dme.13576>. Go to original source... Go to PubMed...
    17. Krebs JD, Weatherall M, Corley B et al. Optimizing the management of hypoglycaemia in individuals with type 2 diabetes: A randomized crossover comparison of a weight-based protocol compared with two fixed-dose glucose regimens. Diabetes Obes Metab 2018; 20(5): 1256-1261. Dostupné z DOI: <http://dx.doi.org/10.1111/dom.13231>. Go to original source... Go to PubMed...
    18. Yale JF, Dulude H, Egeth M et al. Faster use and fewer failures with needle-free nasal gucagon versus injectable glucagon in severe hypoglycemia rescue: a simulation study. Diabetes Technol Ther 2017; 19(7): 423-432. Dostupné z DOI: <http://dx.doi.org/10.1089/dia.2016.0460>. Go to original source... Go to PubMed...
    19. Wiethop BV, Cryer PE. Alanine and Terbutaline in Treatment of Hypoglycemia in IDDM. Diabetes Care 1993; 16(8): 1131-1136. Go to original source... Go to PubMed...
    20. Hall-Boyer K, Zaloga GP, Chernow B. Glucagon: hormone or therapeutic agent? Crit Care Med 1974; 12(7): 584-589. Go to original source...
    21. Lee H, Hosein EA. Chronic alcohol feeding and its withdrawal on the structure and function of the rat liver plasma membrane: a study with 125I-labelled glucagon binding as a metabolic probe. Can J Physiol Pharmacol 1982; 60(9): 1171-1176. Go to original source... Go to PubMed...
    22. American Medical Association. Division of Drugs and Toxicology. Drug evaluations annual 1994. American Medical Association: Chicago 1993. ISBN 0899706029 9780899706023.
    23. Škrha J. Hypoglykémie - důležitý fenomén moderní léčby diabetu mellitu. Remedia 2008; 18(Suppl 1): S34-S41.
    24. [Joint British Diabetes Societies - Inpatient Care Group (JBDS-IP)]. The Hospital Management of Hypoglycaemia in Adults with Diabetes Mellitus. 3rd ed. Revised April 2018. Dostupné z WWW: <https://abcd.care/joint-british-diabetes-societies-jbds-inpatient-care-group> nebo <www.diabetes.org.uk/joint-british-diabetes-society>.
    25. Moore C, Woollard M. Dextrose 10% or 50% in the treatment of hypoglycaemia out of hospital? A randomised controlled trial. Emerg Med J 2005; 22(7): 512-515. <http://dx.doi.org/10.1136/emj.2004.020693>. Go to original source... Go to PubMed...
    26. Kiefer MV, Gene Hern H, Alter HJ et al. Dextrose 10% in the treatment of out-of-hospital hypoglycemia. Prehosp Disaster Med 2014; 29(4): 190-194. <http://dx.doi.org/10.1017/S1049023X14000284>. Go to original source... Go to PubMed...
    27. Klein-Schwartz W, Stassinos GL, Isbister GK. Treatment of sulfonylurea and insulin overdose. Br J Clin Pharmacol 2016; 81(3): 496-504. Dostupné z DOI: <http://dx.doi.org/10.1111/bcp.12822>. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.